620611-27-0

Basic information

• Product Name: 4-Aminomethyl-4-fluoro-piperidine-1-carboxylic acid tert-butyl ester
• Synonyms: 4-Aminomethyl-4-fluoro-piperidine-1-carboxylic acid tert-butyl ester;1-PIPERIDINECARBOXYLIC ACID, 4-(AMINOMETHYL)-4-FLUORO-, 1,1-DIMETHYLETHYL ESTER;TERT-BUTYL 4-(AMINOMETHYL)-4-FLUOROPIPERIDINE-1-CARBOXYLATE;1-Boc-4-(aMinoMethyl)-4-fluoropiperidine;1-Boc-4-(aMinoMethyl)-4-f...;1-Boc-4-fluoro-4-(aMinoMethyl)-piperidine;4-Aminomethyl-4-fluoro-piperidine-1-carboxylic acid tert-butyl ester PUIRTY:>95%
• CAS NO: 620611-27-0
• Molecular Formula: C₁₁H₂₁FN₂O₂
• Molecular Weight: 232.297
• Mol File: 620611-27-0.mol

Chemical Properties

• Boiling Point: 302.4 °C at 760 mmHg
• Flash Point: 136.7 °C
• Appearance: /
• Density: 1.09 g/cm³
• Refractive Index: 1.483
• Storage Temp.: under inert gas (nitrogen or Argon) at 2–8 °C
• PKA: 10.13±0.29(Predicted)
• CAS DataBase Reference: 4-Aminomethyl-4-fluoro-piperidine-1-carboxylic acid tert-butyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: 4-Aminomethyl-4-fluoro-piperidine-1-carboxylic acid tert-butyl ester(620611-27-0)
• EPA Substance Registry System: 4-Aminomethyl-4-fluoro-piperidine-1-carboxylic acid tert-butyl ester(620611-27-0)

Safety Data

• Hazardous Substances Data: 620611-27-0(Hazardous Substances Data)

Usage

InChI:InChI=1/C11H21FN2O2/c1-10(2,3)16-9(15)14-6-4-11(12,8-13)5-7-14/h4-8,13H2,1-3H3

Upstream product

• 918431-93-3 4-cyano-4-fluoro-piperidine-1-carboxylic acid tert-butyl ester 
• 620611-28-1 4-[(1,3-dioxoisoindolin-2-yl)methyl]-4-fluoropiperidinecarboxylic acid tert-butyl ester 
• 1228765-02-3 tert-butyl 4-azidomethyl-4-fluoropiperidine-1-carboxylate 
• 147804-30-6 1-oxa-6-aza-spiro-[2.5]octane-6-caboxylic acid tert-butyl ester 
• 614730-97-1 4-fluoro-4-(hydroxymethyl)piperidine-1-carboxylic acid tert-butyl ester 
• 918431-90-0 tert-butyl 4-fluoro-4-((tosyloxy)methyl)piperidine-1-carboxylate 

Downstream Products

• 918431-91-1 tert-butyl 4-fluoro-4-((3-fluoro-5-(trifluoromethyl)benzamido)methyl)piperidine-1-carboxylate 
• 918431-94-4 tert-butyl 4-((3,5-dichlorobenzamido)methyl)-4-fluoropiperidine-1-carboxylate 

Relevant articles and documents

AMIDE COMPOUNDS AS 5-HT4 RECEPTOR AGONISTS

The present invention relates to compounds of formula (I), including their stereoisomers and pharmaceutically acceptable salts. This invention also relates to methods of making such compounds and pharmaceutical compositions comprising such compounds. The compounds of this invention are useful in the treatment of various disorders that are related to 5-hydroxytryptamine 4 (5-HT4) receptor.

INDAZOLE COMPOUNDS AS 5-HT4 RECEPTOR AGONISTS

The present invention relates to novel indazole compounds of the Formula (I), wherein, R1 is alkyl or cycloalkyl; (Formula II) including their stereoisomers and their pharmaceutically acceptable salts. This invention also relates to methods of making such compounds and pharmaceutical compositions comprising such compounds. The compounds of this invention are useful in the treatment of various disorders that are related to 5-Hydroxytryptamine 4 (5-HT4) receptor agonists

5-AMINO-QUINOLINE-8-CARBOXAMIDE DERIVATIVES AS 5-HT4 RECEPTOR AGONISTS

The present invention relates to novel quinoline compounds of formula (I), and their pharmaceutically acceptable salts and process for their preparation. The compounds of formula (I) are useful in the treatment of various disorders that are related to 5-HT4 receptor agonists.

Novel Compounds for the Treatment of Diseases Associated with Amyloid or Amyloid-like Proteins

The present invention relates to novel compounds that can be employed in the treatment of a group of disorders and abnormalities associated with amyloid protein, such as Alzheimer's disease, and of diseases or conditions associated with amyloid-like prote

Novel compounds for the treatment of diseases associated with amyloid or amyloid-like proteins

The present invention relates to novel compounds that can be employed in the treatment of a group of disorders and abnormalities associated with amyloid protein, such as Alzheimer's disease, and of diseases or conditions associated with amyloid-like prote

Synthesis of aminomethylated 4-fluoropiperidines and 3-fluoropyrrolidines

A short and efficient synthesis of 4-aminomethyl-4-fluoropiperidines and 3-aminomethyl-3-fluoropyrrolidines is described. These fluorinated azaheterocycles are of specific interest as bifunctional building blocks for fluorinated pharmaceutical compounds.

Design, synthesis, and evaluation of a novel 4-aminomethyl-4- fluoropiperidine as a T-type Ca2+ channel antagonist

The novel T-type antagonist (S)-5 has been prepared and evaluated in in vitro and in vivo assays for T-type calcium ion channel activity. Structural modification of the piperidine leads 1 and 2 afforded the fluorinated piperidine (S)-5, a potent and selec

4-FLUORO-PIPERIDINE T-TYPE CALCIUM CHANNEL ANTAGONISTS

The present invention is directed to 4-fluoro-piperidine compounds which are antagonists of T-type calcium channels, and which are useful in the treatment or prevention of neurological and psychiatric disorders and diseases in which T-type calcium channel

4,4-DISUBSTITUTED PIPERIDINE DERIVATIVES HAVING CCR3 ANTAGONISM

The invention provides low molecular compounds having activity which inhibits binding of CCR3 ligands to CCR3 on target cells, i.e. CCR3 antagonists. The invention also provides 4,4-(disubstituted)piperidine derivatives represented by formula (I) below, pharmaceutically acceptable acid adducts thereof, or pharmaceutically acceptable C1-C6 alkyl adducts thereof, as well as pharmaceutical compositions comprising them as effective ingredients, which are useful for treatment or prevention of diseases associated with CCR3, such as asthma and allergic rhinitis.